Blog Articles, tagged with: Ocrelizumab

Ocrelizumab

Thumbnail

Ocrelizumab recommended for licencing by European Medicines Agency for relapsing remitting and early primary progressive MS The European Medicines Agency recommends licensing for ocrelizumab (Ocrevus) for treating relapsing and primary progressive MS. The European Medicines Agency (EMA) has rec...

Published by MS Ireland on Monday November 13 2017 10:02 AM

View Article

Hope

Thumbnail

‘This week Helen Farrell examines how the years of living with MS have made an impact on her hopes for the future’ This week a brand new MS medication, Ocrevus (ocrelizumab), was approved by the Federal Drugs Authority (FDA)in the United States for both primary progressive (PPMS) and...

Published by Helen Farrell on Thursday April 06 2017 11:00 AM

View Article

Ocrelizumab

Thumbnail

First treatment licensed for primary progressive MS in the US Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. It is the first licensed treatment for people with primary progressive MS. The decision was made by the US Food and Drug Administrat...

Published by MS Ireland on Thursday March 30 2017 03:09 PM

View Article

Clinical Trial Recruiting

Thumbnail

**NO LONGER RECRUITING** A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)  A clinical trial for potential new therapy Ocrelizumab is recruiting in Irish centres. Ocrelizumab has been found to have potential benefits for both relapsing remitting MS a...

Published by MS Ireland on Wednesday February 15 2017 10:14 AM

View Article

Ocrelizumab

Thumbnail

Ocrelizumab is a new medication which has recently been shown in three, large phase-three clinical trials to have beneficial effects in both relapsing-remitting and primary progressive MS. When available, Ocrelizumab will be a welcome addition to the number of drugs currently licensed for relapsi...

Published by MS Ireland on Tuesday January 03 2017 10:28 AM

View Article


Latest News

More news

What's hot

Tcd

Public Lecture

'MS Research Explored': Thursday, 30th November 2017 at 6pm, Trinity Biomedical Sciences Institute, Dublin 2. All welcome

Find out more

Events Calendar

» Our next Event

24 November 2017: Yoga group classes, every Friday for 1 1/2 hours per week. Classes commence 29th September for 10 weeks

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow